MEK-ERK Pathway Modulation Ameliorates Disease Phenotypes in a Mouse Model of Noonan Syndrome Associated With the Raf1L613V Mutation

Journal of Clinical Investigation - United States
doi 10.1172/jci44929
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

American Society for Clinical Investigation

Related search

Modulation of the Akt/Ras/Raf/Mek/Erk Pathway by A3 Adenosine Receptor

Purinergic Signalling
Molecular NeuroscienceCell BiologyMolecular BiologyCellular
2006English

A First Case Report of Subependymoma in PTPN11 Mutation-Associated Noonan Syndrome

Case Reports in Neurological Medicine
2019English

A YWHAZ Variant Associated With Cardiofaciocutaneous Syndrome Activates the RAF-ERK Pathway

Frontiers in Physiology
Physiology
2019English

Cancer Risk in Patients With Noonan Syndrome Carrying a PTPN11 Mutation

European Journal of Human Genetics
Genetics
2011English

Noonan Syndrome: Comparing Mutation-Positive With Mutation-Negative Dutch Patients

Molecular Syndromology
Genetics
2013English

Modulation of mtDNA Copy Number Ameliorates the Pathological Consequences of a Heteroplasmic mtDNA Mutation in the Mouse

Science advances
Multidisciplinary
2019English

Genotype and Phenotype in Patients With Noonan Syndrome and a RIT1 Mutation

Genetics in Medicine
MedicineGenetics
2016English

Leukemia Inhibitory Factor (LIF) Withdrawal Activates mTOR Signaling Pathway in Mouse Embryonic Stem Cells Through the MEK/ERK/TSC2 Pathway

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2016English

Targeting the Ras/Raf/Mek/Erk Pathway in Hepatocellular Carcinoma (Review)

Oncology Letters
Cancer ResearchOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy